In vitro activity of β-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: Correlation between drug resistance and genetic characteristics

Journal of Infection and Chemotherapy

Volumn 11, Issue 5, 2005, Pages 262-264

  Yamaguchi, Toshiyuki ^a   Hashikita, Giichi ^a   Takahashi, Shun ^a   Itabashi, Akira ^a   Yamazaki, Tsutomu ^a   Maesaki, Shigefumi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ermB; mefA; PBP; PRSP

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BIAPENEM; CEFDITOREN; CEFEPIME; CEFOTIAM; CEPHEM DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; FROPENEM; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; PANIPENEM; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; GENETIC VARIABILITY; IN VITRO STUDY; JAPAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 27644566102     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-005-0405-z     Document Type: Article

References (12)

1. K Shimada K Nakano I Ohno S Okada K Hayashi H Yokouchi 2001 Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics Jpn J Antibiot 54 331 64
2. K Ubukata N Chiba K Hasegawa R Kobayashi S Iwata K Sunakawa 2004 Antibiotic susceptibility in relation to penicillin-binding protein genes and serotype distribution of Streptococcus pneumoniae strains responsible for meningitis in Japan, 1999 to 2002 Antimicrob Agents Chemother 48 1488 94
3. AP [tmp] MacGowan R Wise 2001 Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests J Antimicrob Chemother 48 Suppl. S1 17 28
4. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M7-A5. Wayne, PA:NCCLS;2000
5. K Nagai Y Shibasaki K Hasegawa TA Davies MR Jacobs K Ubukata 2001 Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants J Antimicrob Chemother 48 915 8
6. KP Klugman 1990 Pneumococcal resistance to antibiotics Clin Microbiol Rev 3 171 96
7. J Shimada N Yamanaka M Hotomi M Suzumoto A Sakai K Ubukata 2002 Household transmission of Streptococcus pneumoniae among siblings with acute otitis media J Clin Microbiol 40 1851 3
8. L Saravolatz O Manzor C Check J Pawlak B Belian 2001 Antimicrobial activity of moxifloxacin, gatifloxacin, and six fluoroquinolones against Streptococcus pneumoniae J Antimicrob Chemother 47 875 7
9. DK Chen A [tmp] McGeer JC de Azavedo DE Low 1999 Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada N Engl J Med 341 233 9
10. PL Ho TL Que DN Tsang TK Ng KH Chow WH Seto 1999 Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong Antimicrob Agents Chemother 43 1310 3
11. K Yamaguchi S Miyazaki F Kashitani M Iwata L-S Group 2000 Activities of antimicrobial agents against 5180 clinical isolates obtained from 26 medical institutions during 1998 in Japan Jpn J Antibiot 53 387 408
12. S Yokota K Sato O Kuwahara S Habadera N Tsukamoto H Ohuchi 2002 Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequently in elderly patients in Japan Antimicrob Agents Chemother 46 3311 5